Resultados de Búsqueda
Patiromer is recommended as an option for treating hyperkalaemia in adults.
NICE
National Institute for Health and Clinical Excellence (NICE)
only if used: - in emergency care for acute life-threatening hyperkalaemia alongside standard care or - for people with persistent hyperkalaemia and stages 3b to 5 chronic kidney disease or heart failure, if they: - have a confirmed serum potassium level of at least 6.0 mmol/litre and - are not taking, or are taking a reduced dosage of, a renin-angiotensin-aldosterone system (RAAS) inhibitor because of hyperkalaemia and - are not on dialysis. Stop patiromer ...
ver más ... 20201.1 Sotagliflozin with insulin is recommended as an option for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2, when insulin alone does not provide adequate ...
NICE
National Institute for Health and Clinical Excellence (NICE)
Stop sotagliflozin if there has not been a sustained improvement in glycaemic control (that is, a fall in HbA1c level of about 0.3% or 3 mmol/mol). These recommendations are not intended to affect treatment with sotagliflozin that was started in the NHS before this guidance was published. People having treatment outside these recommendations may continue without change to the funding arrangements in place for them before this guidance was published, until they and their NHS clinician consider ...
ver más ... 2020Dapagliflozin with insulin is recommended as an option for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2, when insulin alone does not provide adequate glycaemic ...
NICE
National Institute for Health and Clinical Excellence (NICE)
Stop dapagliflozin if there has not been a sustained improvement in glycaemic control (that is, a fall in HbA1c level of about 0.3% or 3 mmol/mol). Evidence from the clinical trials shows small improvements in blood glucose (HbA1c levels) and weight loss, and very small improvements in quality of life, when dapagliflozin plus insulin is compared with placebo plus insulin in adults with type 1 diabetes and inadequate blood glucose control despite optimised insulin therapy. The company ...
ver más ... 2020Dapagliflozin with insulin is recommended as an option for treating type 1 diabetes in adults with a body mass index (BMI) of at least 27 kg/m2, when insulin alone does not provide adequate glycaemic ...
NICE
National Institute for Health and Clinical Excellence (NICE)
Stop dapagliflozin if there has not been a sustained improvement in glycaemic control (that is, a fall in HbA1c level of about 0.3% or 3 mmol/mol). Evidence from the clinical trials shows small improvements in blood glucose (HbA1c levels) and weight loss, and very small improvements in quality of life, when dapagliflozin plus insulin is compared with placebo plus insulin in adults with type 1 diabetes and inadequate blood glucose control despite optimised insulin therapy. The company ...
ver más ... 2020Evidence on the safety and efficacy of cyanoacrylate glue occlusion for varicose veins is adequate to support the use of this procedure provided that standard arrangements are in place for clinical ...
NICE
National Institute for Health and Clinical Excellence (NICE)
The procedure should only be done by clinicians with appropriate training in this procedure and experience in the use of venous ultrasound.
ver más ... 2020